Alexander Nowak
Stock Analyst at Craig-Hallum
(2.60)
# 2,165
Out of 4,876 analysts
45
Total ratings
44.44%
Success rate
4.77%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $5.82 | +278.01% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $167.96 | -6.53% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $6.77 | +151.11% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $28.87 | +97.44% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $12.54 | +115.31% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $19.23 | -22.00% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $3.84 | +108.33% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $2.60 | +592.31% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $18.94 | +163.99% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $14 → $8 | $0.70 | +1,042.86% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $53.65 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.68 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.29 | +380.35% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $51.84 | +112.19% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.49 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $3.28 | +9,046.34% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $6.12 | +357.52% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $5.82
Upside: +278.01%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $167.96
Upside: -6.53%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.77
Upside: +151.11%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $28.87
Upside: +97.44%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $12.54
Upside: +115.31%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $19.23
Upside: -22.00%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $3.84
Upside: +108.33%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $2.60
Upside: +592.31%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $18.94
Upside: +163.99%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.70
Upside: +1,042.86%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $53.65
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.68
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.29
Upside: +380.35%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $51.84
Upside: +112.19%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.49
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $3.28
Upside: +9,046.34%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $6.12
Upside: +357.52%